The COMPPARE team was pleased to announce on November 13, 2020 that the study had enrolled 1,000 patients, one-third of its 3,000-patient goal. COMPPARE’s partner site, the James M. Slater, MD Proton Treatment & Research Center, Loma Linda, CA, enrolled the 1,000th patient. COMPPARE stands for “A Prospective COMparative Study…

English Version Download PDF Spanish Version Download PDF…

English and spanish versions COMPPARE Brochures Learn why this study will help future patients make evidence-based treatment decisions.

Thank you for your interest in the COMPPARE study. COMPPARE stands for “A Prospective COMparative Study of Outcomes with Proton and Photon RAdiation in PRostate CancEr (COMPPARE).” This study, which is funded by the Patient-Centered Outcomes Research Institute (PCORI) and approved by the University of Florida Institutional Review Board…

Thank you for your interest in the COMPPARE study. COMPPARE stands for “A Prospective COMparative Study of Outcomes with Proton and Photon RAdiation in PRostate CancEr (COMPPARE).” This study is funded by the Patient-Centered Outcomes Research Institute (PCORI) and led by Dr. Nancy Mendenhall at the…

Step 1: Meet with your Radiation Oncologist and the study staff to determine if COMPPARE is right for you. If so, in Step 2, give your consent to participate and register for the study. Step 3: Complete the Pretreatment Questionnaires. Step 4: Receive the radiation…

Study Overview What is COMPPARE? What is the goal of COMPPARE? Who is eligible for COMPPARE? How does participation in COMPPARE work? Why is COMPPARE important for patients? What is the benefit of participating in COMPPARE? How can I learn more about…